Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector

Vaccine

Volumn 29, Issue 51, 2011, Pages 9544-9550

  Simon, Jakub K ^a   Carter, Mihaela ^a   Pasetti, Marcela F ^a   Sztein, Marcelo B ^a   Kotloff, Karen L ^a   Weniger, Bruce G ^b   Campbell, James D ^a   Levine, Myron M ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Immunogenicity; Influenza; Jet injection; LectraJet M3 RA; Safety; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNOGENICITY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; JET INJECTOR; MALE; NONHUMAN; PRIORITY JOURNAL; UNITED STATES;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INJECTIONS, INTRAMUSCULAR; INJECTIONS, JET; MALE; MIDDLE AGED; VACCINES, INACTIVATED;

EID: 81955164188     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.09.097     Document Type: Article

References (22)

1. Giudice E.L., Campbell J.D. Needle-free vaccine delivery. Adv Drug Deliv Rev 2006, 58(20 April (1)):68-89.
2. Lloyd J. Technologies for vaccine delivery in the 21st century. World Health Organization, Department of Vaccines and Biologicals; 2000.
3. Levine M.M. Can needle-free administration of vaccines become the norm in global immunization?. Nat Med 2003, 9(January (1)):99-103.
4. Weniger BG. Jet injection of vaccines: overview and challenges for mass vaccination with jet injectors (JIs). In: Conference on innovative administration systems for vaccines, Rockville, MD, USA, 18-19 December. Available from: 2003 [cited 20 May 2011]. http://www.hhs.gov/nvpo/meetings/dec2003/Contents/ThursdayPM/Weniger.pdf.
5. Hingson R.A., Hughes J.G. Clinical studies with jet injection; a new method of drug administration. Curr Res Anesth Anal 1947, 26(6):221-230.
6. Canter J., Mackey K., Good L.S., Roberto R.R., Chin J., Bond W.W., et al. An outbreak of hepatitis B associated with jet injections in a weight reduction clinic. Arch. Intern. Med. 1990, 150(9):1923-1927.
7. Weniger B.G., Papania M.J. Alternative Vaccine Delivery Methods [Chapter 61]. Vaccines 2008, 1357-1392. Saunders (Elsevier), Philadelphia, PA. 5th ed. S.A. Plotkin, W.A. Orenstein, P.A. Offit (Eds.).
8. United States Food and Drug Administration. Section 510(k) premarket notification no. K090959: LectraJet Needle Free Infection System. Approved 24 December; 2009, http://www.accessdata.fda.gov/cdrh_docs/pdf9/K090959.pdf.
9. Global Influenza P. WHO manual on animal influenza diagnosis and surveillance. Available from: 2002. http://www.wpro.who.int/internet/resources.ashx/CSR/Publications/manual+on+animal+ai+diagnosis+and+surveillance.pdf.
10. WHO Collaborative Center for Influenza. Biological Products Division. The hemagglutination inhibition test for influenza viruses; 1975.
11. Simonsen L., Kane A., Lloyd J., Zaffran M., Kane M. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ 1999, 77(10):789-800.
12. Dicko M., Oni A.Q., Ganivet S., Kone S., Pierre L., Jacquet B. Safety of immunization injections in Africa: not simply a problem of logistics. Bull World Health Organ 2000, 78(2):163-169.
13. Miller M.A., Pisani E. The cost of unsafe injections. Bull World Health Organ 1999, 77(10):808-811.
14. Pruss-Ustun A., Rapiti E., Hutin Y. Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am J Ind Med 2005, 48(6):482-490.
15. Simon JK, Levine MM, Weniger BG, Restrepo AMH, Dougan G, Good MF, et al. Mucosal immunization and needle-free injection devices. In: New generation vaccines. New York, NY: Informa Healthcare USA, Inc.; 2010. p. 405-14.
16. Parent du Châtelet I., Lang J., Schlumberger M., Vidor E., Soula G., Genet A., et al. Clinical immunogenicity and tolerance studies of liquid vaccines delivered by jet-injector and a new single-use cartridge (Imule): comparison with standard syringe injection. Imule Investigators Group. Vaccine 1997, 15(4):449-458.
17. Fisch A., Cadilhac P., Vidor E., Prazuck T., Dublanchet A., Lafaix C. Immunogenicity and safety of a new inactivated hepatitis A vaccine: a clinical trial with comparison of administration route. Vaccine 1996, 14(12):1132-1136.
18. Williams J., Fox-Leyva L., Christensen C., Fisher D., Schlicting E., Snowball M., et al. Hepatitis A vaccine administration: comparison between jet-injector and needle injection. Vaccine 2000, 18(18):1939-1943.
19. Jackson L.A., Austin G., Chen R.T., Stout R., DeStefano F., Gorse G.J., et al. Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. Vaccine 2001, 19(32):4703-4709.
20. Sarno M.J., Blase E., Galindo N., Ramirez R., Schirmer C.L., Trujillo-Juarez D.F. Clinical immunogenicity of measles, mumps and rubella vaccine delivered by the Injex jet injector: comparison with standard syringe injection. Pediatr. Infect. Dis. J. 2000, 19(9):839-842.
21. Mathei C., Van Damme P., Meheus A., Hepatitis B vaccine administration: comparison between jet-gun and syringe and needle. Vaccine 1997, 15(March (4)):402-404.
22. Guidance for Industry: Clinical data needed to support the licensure of seasonal inactivated influenza vaccines. Available from: 2007 [cited 2010/08/19]. http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm091990.pdf.